QCLS Q/C Technologies, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$0,75
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,4252-Wochen-Tief
$8,1752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$6M
P/E
-0.5
EPS
$-8.66
Ihre Abzeichen
52W-Spanne
$0–$8
Analystenbewertung
·
Kursziel
·
P/E
-0.5
ROE
·
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
QCLS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.75
Marktkapitalisierung (MRQ)
$6M
P/E
-0.5
EPS
$-8.66
52W-Spanne
$0–$8
QCLS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 2. September 2025 | 1-for-100 | Umgekehrt |
| 15. Februar 2024 | 1-for-30 | Umgekehrt |
| 19. April 2021 | 1-for-2 | Umgekehrt |
| 25. November 2019 | 1-for-24 | Umgekehrt |
| 8. November 2018 | 1-for-8 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2016-12-31 → 2018-12-31
EPS$-8.662022-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2018-12-31
Nettogewinnmarge·2017-12-31 → 2018-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | QCLS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.55-Jahres-Durchschnitt ≈-110.1 | ≈-110.1 | · | · | |
| K/B (MRQ) | 0.45-Jahres-Durchschnitt ≈3144.3 | ≈3144.3 | 1.8 | Fairer Wert | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 838.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | QCLS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.35-Jahres-Durchschnitt ≈4.2 | ≈4.2 | 4.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-225.9%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. Dezember 2017 | $-230400.00 | $70502.40 | -426.8% | |
| 30. September 2017 | $-149760.00 | $0.00 | — | |
| 30. Juni 2017 | $-92160.00 | $-47001.60 | -96.1% | |
| 31. März 2015 | $-299520.00 | $-117504.00 | -154.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $2M | $3M | $3M | $2M | $4M | |
| Cost of Revenue | · | · | · | · | · | · | · | $2M | $2M | $138.7K | $115.4K | $71.4K | |
| Gross Profit | · | · | · | · | · | · | · | $127.3K | $948.6K | $2M | $1M | $3M | |
| R&D Expense | $3M | $3M | $8M | $9M | $7M | $2M | · | $1M | $1M | $1M | $1M | $916.3K | |
| SG&A Expense | $4M | $4M | $5M | $6M | $6M | $3M | $3M | $6M | $4M | $3M | $4M | $4M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | $-55.7K | |
| Operating Income | $-10M | $-10M | $-17M | $-15M | $-29M | $-9M | $-3M | $-10M | $-7M | $-3M | $-10M | $-3M | |
| Other Non-op | $-2M | $-13M | $13M | $85.4K | $-1M | $141 | $90.8K | $788.6K | $752.5K | $25.1K | $-101.0K | $-77.0K | |
| Pretax Income | $-12M | $-23M | $-4M | $-15M | $-30M | $-9M | $-3M | $-11M | $-7M | $-3M | $-10M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $-269.3K | · | |
| Net Income | $-12M | $-23M | $-4M | $-15M | $-30M | $-9M | $-4M | $-11M | $-7M | $-3M | $-9M | $-3M | |
| EPS (Basic) | $-8.66 | $-1080.87 | $-5.33 | $-11.74 | $-0.85 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-8.66 | $-1080.87 | $-5.33 | $-11.74 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,729,946 | 25,129 | 1,542,453 | 1,294,200 | 35,017,244 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 1,729,946 | 25,129 | 1,542,453 | 1,294,200 | · | · | · | · | · | · | · | · | |
| EBITDA | · | $-10M | $-17M | $-15M | $-29M | $-12M | · | $-10M | $-6M | · | · | $-3M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $987.0K | $173.2K | $3M | $749.1K | $556.0K | $148.3K | $517.4K | $181.8K | $438.4K | $72.7K | $402.1K | $455.8K | |
| Short-term Investments | $15M | $8M | $2M | $4M | $11M | · | $9M | $5M | $5M | $50.0K | $4M | $9M | |
| Receivables | · | · | · | · | · | · | · | $176.3K | $964.7K | $601.3K | $609.2K | $1M | |
| Inventory | · | · | · | · | · | $197.7K | · | $585.3K | $947.6K | $2M | $1M | $905.1K | |
| Prepaid Expense | $774.1K | $893.7K | $893.2K | $565.8K | $1M | $1.2K | $334.1K | $444.4K | $397.0K | $168.3K | $186.0K | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $186.0K | $107.6K | |
| Current Assets | $17M | $9M | $6M | $5M | $13M | $149.5K | $10M | $7M | $8M | $3M | $6M | $13M | |
| PP&E (Net) | · | · | · | · | · | · | · | $83.5K | $235.1K | $259.4K | $251.1K | $201.5K | |
| PP&E (Gross) | · | · | · | · | · | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | · | · | · | · | · | · | $2M | $2M | $2M | $2M | $-2M | $-2M | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Intangibles | $14M | · | · | · | · | · | · | $243.4K | $1M | $1M | $1M | $2M | |
| Other Non-current Assets | · | · | · | · | · | · | $2.7K | $12.0K | $76.1K | $66.8K | $66.8K | $4.3K | |
| Total Assets | $41M | $21M | $18M | $18M | $25M | $676.7K | $11M | $8M | $9M | $5M | $8M | $17M | |
| Accounts Payable | $2M | $3M | $4M | $3M | $986.6K | $1M | $891.9K | $2M | $2M | $1M | $2M | $2M | |
| Accrued Liabilities | $373.0K | $386.7K | $637.1K | $316.7K | $119.1K | · | $232.8K | $1M | $736.5K | · | · | · | |
| Short-term Debt | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $6M | $7M | $5M | $3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | $75.9K | $95.9K | $51.6K | · | · | · | · | · | · | |
| Total Liabilities | $16M | $7M | $5M | $3M | $1M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Common Stock | $7.7K | $3.4K | $2.0K | $1.3K | $102M | $4.0K | $129M | $122M | $111M | $101M | $101M | $100M | |
| Paid-in Capital | $166M | $139M | $114M | $108M | · | $43M | · | · | · | · | · | · | |
| Retained Earnings | $-144M | $-129M | $-102M | $-94M | $-79M | $-49M | $-120M | $-116M | $-105M | $-97M | $-94M | $-85M | |
| AOCI | · | · | · | · | · | · | $17.9K | $-25.9K | · | · | $-6.2K | $-20.1K | |
| Stockholders' Equity | $22M | $10M | $12M | $15M | $24M | $-5M | $-2M | $6M | $8M | $3M | $7M | $15M | |
| Liabilities + Equity | $41M | $21M | $18M | $18M | $25M | $676.7K | $11M | $8M | $9M | $5M | $8M | $17M | |
| Shares Outstanding | 7,690,403 | 33,636 | 2,018,857 | 1,315,674 | 37,673,110 | 28,553,307 | 1,738,837 | 540,607 | 5,534,692 | 5,452,545 | 5,425,045 | 4,954,837 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $29.5K | $74.1K | $234.5K | $249.9K | $286.2K | $300.0K | $349.4K | |
| Stock-based Comp | $2M | $1M | $3M | $695.2K | · | $855.0K | · | $12.5K | $5.5K | $51.7K | $52.4K | $549.6K | |
| Deferred Tax | $-2M | $-5M | $4M | $-6M | $-6M | $-2M | $-738.0K | $-3M | $-6M | $-751.0K | $835.6K | $132.4K | |
| Amort. of Intangibles | · | · | · | · | · | $18.3K | $40.0K | $171.1K | $171.1K | $171.1K | $236.7K | $258.6K | |
| Other Non-cash | · | · | · | · | · | $8M | · | $5M | $8M | · | · | $-2M | |
| Operating Cash Flow | $-9M | $-9M | $-13M | $-12M | $-20M | $-5M | $-3M | $-9M | $-5M | $-4M | $-5M | $-4M | |
| CapEx | $2M | · | · | · | · | · | · | $68.2K | $54.5K | $123.3K | $113.0K | $25.0K | |
| Investing Cash Flow | $-8M | $-6M | $2M | $7M | $20M | · | $-4M | $-359.7K | $-5M | $4M | · | · | |
| Stock Issued | · | · | · | $6M | · | $2M | $2M | $2M | $6M | · | · | $745.0K | |
| Net Stock Activity | · | · | · | $6M | · | $29M | · | $2M | $6M | · | · | · | |
| Financing Cash Flow | $18M | $13M | $13M | $6M | $73.5K | $5M | $7M | $9M | $10M | · | · | · | |
| Net Change in Cash | $813.8K | $-3M | $2M | $193.1K | $407.7K | $13.8K | $-49.2K | $243.3K | $365.7K | $-329.4K | $-53.8K | $352.2K | |
| Taxes Paid | · | · | · | · | · | · | · | $2.1K | $1.7K | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $-9M | $-5M | · | · | $-4M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 7.6% | 28.3% | · | · | 73.5% | |
| Operating Margin | · | · | · | · | · | · | · | -604.0% | -197.2% | · | · | -72.4% | |
| Net Margin | · | · | · | · | · | · | · | -651.4% | -219.6% | · | · | -70.6% | |
| Pretax Margin | · | · | · | · | · | · | · | -651.4% | -219.6% | · | · | -70.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | -589.9% | -189.7% | · | · | -64.5% | |
| ROA | · | -118.9% | -22.6% | -71.8% | -234.5% | -73.7% | · | -126.6% | · | · | · | -27.5% | |
| ROE | · | -175.8% | -28.7% | -92.0% | -120.7% | -115.8% | · | -160.1% | · | · | · | -33.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.4 | 1.2 | 2.0 | 12.2 | 16.3 | · | · | · | · | · | 7.1 | |
| Quick Ratio | · | 1.3 | 1.0 | 1.7 | 11.1 | 15.6 | · | · | · | · | · | 6.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.2 | · | · | · | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.0 | · | · | · | 1.2 | |
| Receivables Turnover | · | · | · | · | · | · | · | 2.9 | · | · | · | 4.1 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.91 | $6.13 | $0.37 | · | $1.97 | · | $0.47 | · | · | · | $2.99 | |
| Cash Flow / Share | · | $-3.68 | $-8.42 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.05 | $1.33 | $0.02 | · | $1.06 | · | $0.01 | · | · | · | $0.09 | |
| EPS (TTM) | $-8.66 | $-1080.87 | $-5.33 | $-11.74 | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $4M | |
| Net Income TTM | $-12M | $-23M | $-4M | $-15M | $-30M | $-9M | $-4M | $-11M | $-7M | $-3M | $-9M | $-3M | |
| Market Cap | · | $387M | $1.57B | $136.17B | · | $209.97B | · | $2.03T | · | · | · | $22.77T | |
| P/E | -0.5 | -0.1 | -145.8 | -293.9 | · | · | · | · | · | · | · | · | |
| P/S | · | 179.1 | 726.1 | 63032.9 | · | 97192.7 | · | 1219514.2 | · | · | · | 5144322.1 | |
| P/B | · | 39.5 | 126.8 | 9266.5 | · | 6072.0 | · | 348178.3 | · | · | · | 1538122.8 | |
| P / Tangible Book | · | · | 838.4 | 32448.7 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -43.1 | -120.8 | -11097.9 | · | -17607.5 | · | -238475.8 | · | · | · | -5863858.3 | |
| P / FCF | · | · | · | · | · | · | · | -236581.0 | · | · | · | -5826373.2 | |
| Earnings Yield | -217.0% | -939.9% | -0.69% | -0.34% | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $236.1K | $510.5K | $696.5K | $356.4K | $873.5K | $2M | $1M | $707.7K | $401.1K | $1M | $3M | $2M | $2M | $770.4K | $2M | $2M | |
| SG&A Expense | $1M | $1M | $1M | $967.8K | $894.3K | $841.7K | $969.1K | $1M | $1M | $1M | $1M | $1M | $2M | $988.0K | $1M | $2M | |
| Operating Expenses | $4M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Income | $-7M | $-2M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-5M | $-4M | $-6M | $-3M | $-4M | $-4M | |
| Other Non-op | $-3M | $612.4K | $-2M | $-1M | $76.4K | $1M | $124.6K | $-103.8K | $-6M | $-7M | $3M | $8M | $2M | $1M | $62.5K | $16.2K | |
| Pretax Income | $-7M | $-1M | $-6M | $-3M | $-2M | $-1M | $-2M | $-2M | $-10M | $-10M | $-2M | $4M | $-4M | $-2M | $-4M | $-4M | |
| Net Income | $-7M | $-1M | $-6M | $-3M | $-2M | $-1M | $-2M | $-2M | $-10M | $-10M | $-2M | $4M | $-4M | $-2M | $-4M | $-4M | |
| EPS (Basic) | $-0.79 | $-0.19 | $-5.62 | $-2.50 | $-51.10 | $-0.36 | $-963.57 | $-107.62 | $-4.54 | $-5.14 | $-2.75 | $1.84 | $-3.22 | $-1.20 | $-11.45 | $-0.09 | |
| EPS (Diluted) | $-0.79 | $-0.19 | $-5.62 | $-2.50 | $-51.10 | $-0.36 | $-963.57 | $-107.62 | $-4.54 | $-5.14 | $-1.28 | $0.37 | $-3.22 | $-1.20 | $-11.44 | $-0.09 | |
| Shares (Basic) | 8,235,978 | 8,059,560 | · | 1,483,341 | 54,261 | 5,349,662 | · | 24,907 | 2,275,699 | 2,141,131 | · | 1,564,275 | 1,411,029 | 1,392,210 | · | 39,046,852 | |
| Shares (Diluted) | 8,235,978 | 8,059,560 | · | 1,483,341 | 54,261 | 5,349,662 | · | 24,907 | 2,275,699 | 2,141,131 | · | 7,818,886 | 1,411,029 | · | · | 39,046,852 | |
| EBITDA | $-7M | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-3M | $-3M | · | $-4M | $-6M | $-3M | · | $-4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307.6K | $1M | $987.0K | $7M | $207.6K | $73.2K | $173.2K | $1M | $536.0K | $225.7K | $3M | $298.3K | $93.8K | $188.5K | $749.1K | $309.9K | |
| Short-term Investments | $11M | $12M | $15M | $3M | $4M | $6M | $8M | $9M | $13M | $2M | $2M | $8M | $12M | $15M | $4M | $7M | |
| Prepaid Expense | $736.9K | $714.1K | $774.1K | $1M | $1M | $898.3K | $893.7K | $1M | $1M | $725.2K | $893.2K | $1M | $2M | $738.1K | $565.8K | $993.1K | |
| Current Assets | $12M | $14M | $17M | $11M | $5M | $7M | $9M | $12M | $14M | $2M | $6M | $10M | $13M | $16M | $5M | $8M | |
| PP&E (Net) | $140.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $146.2K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $5.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Intangibles | · | $14M | $14M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $113.7K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $23M | $38M | $41M | $37M | $17M | $19M | $21M | $24M | $26M | $14M | $18M | $22M | $25M | $28M | $18M | $20M | |
| Accounts Payable | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $2M | $2M | $1M | $3M | $2M | |
| Accrued Liabilities | $764.9K | $422.7K | $383.0K | · | · | $428.7K | $386.7K | $455.2K | $524.4K | $511.0K | $637.1K | $685.9K | $497.4K | $169.9K | $316.7K | $324.6K | |
| Current Liabilities | $4M | $4M | $6M | $7M | $6M | $5M | $7M | $7M | $6M | $4M | $5M | $6M | $2M | $2M | $3M | $2M | |
| Capital Leases | $226.0K | · | · | · | · | · | · | · | · | · | · | $20.5K | $39.5K | $58.0K | $75.9K | $93.1K | |
| Total Liabilities | $4M | $15M | $16M | $16M | $6M | $5M | $7M | $7M | $26M | $4M | $5M | $6M | $14M | $14M | $3M | $2M | |
| Common Stock | $8.2K | $7.8K | $184.5K | $179.8K | $29.4K | $7.4K | $3.4K | $2.5K | $2.4K | $2.2K | $2.0K | $112M | $111M | $108M | $1.3K | $108M | |
| Paid-in Capital | $168M | $166M | $166M | $152M | $139M | $140M | $139M | $143M | $123M | $123M | $114M | · | · | · | $108M | · | |
| Retained Earnings | $-152M | $-146M | $-144M | $-138M | $-134M | $-131M | $-129M | $-126M | $-123M | $-113M | $-102M | $-97M | $-100M | $-95M | $-94M | $-90M | |
| Stockholders' Equity | $16M | $21M | $22M | $14M | $5M | $9M | $10M | $17M | $97.8K | $10M | $12M | $16M | $11M | $13M | $15M | $18M | |
| Liabilities + Equity | $23M | $38M | $41M | $37M | $17M | $19M | $21M | $24M | $26M | $14M | $18M | $22M | $25M | $28M | $18M | $20M | |
| Shares Outstanding | 8,189,838 | 7,853,429 | 7,690,403 | 2,977,672 | 29,383,743 | 7,392,565 | 33,636 | 2,472,048 | 2,370,423 | 2,157,632 | 2,018,857 | 47,000,365 | 42,027,113 | 39,470,009 | 1,315,674 | 39,470,009 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $58.6K | $2M | · | $104.9K | $84.6K | $86.5K | $13.8K | $439.6K | $517.4K | $707.6K | $595.6K | $2M | $69.1K | $113.5K | $352.4K | |
| Operating Cash Flow | $-2M | $-3M | $-3M | $-1M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-4M | $-4M | $-2M | $-4M | |
| Investing Cash Flow | $1M | $3M | $-12M | $-1M | $2M | $3M | $1M | $3M | $-11M | $732.0K | $6M | $3M | $4M | $-11M | $3M | $-2M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Dividends Paid | · | · | · | · | · | · | · | $68.1K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-42.9K | $453.9K | $9M | · | · | · | $1 | $-154.8K | $14M | $-1M | $-2M | $0 | $0 | $15M | $0 | · | |
| Net Change in Cash | $-820.0K | $140.6K | $-6M | $7M | $134.3K | $-99.9K | $-1M | $656.3K | $310.4K | $-2M | $2M | $204.5K | $-94.7K | $-560.5K | $439.2K | $-805.2K |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -33.1% | -4.4% | · | -9.2% | -8.2% | -6.8% | · | -8.4% | -37.0% | -45.7% | · | 19.2% | -18.8% | -6.0% | · | -15.3% | |
| ROE | -61.9% | -8.5% | · | -18.1% | -66.8% | -12.1% | · | -11.9% | -176.5% | -85.1% | · | 23.9% | -31.0% | -9.2% | · | -16.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.7 | · | 1.7 | 0.9 | 1.4 | · | 1.7 | 2.5 | 0.6 | · | 1.7 | 5.4 | 10.0 | · | 4.5 | |
| Quick Ratio | 3.1 | 3.5 | · | 1.5 | 0.7 | 1.2 | · | 1.5 | 2.3 | 0.4 | · | 1.5 | 4.8 | 9.6 | · | 4.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $2.64 | · | $4.81 | $0.18 | $1.18 | · | $6.79 | $0.04 | $4.61 | · | $0.33 | $0.26 | $0.33 | · | $0.46 | |
| Cash Flow / Share | · | $-0.41 | · | · | · | $-0.49 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.04 | $0.14 | · | $2.32 | $0.01 | $0.01 | · | $0.48 | $0.23 | $0.10 | · | $0.01 | $0.00 | $0.00 | · | $0.01 | |
| EPS (TTM) | $-9.10 | $-59.41 | · | $-1017.53 | $-1122.65 | $-1076.09 | · | $-118.58 | $-10.59 | $-9.27 | · | $-15.49 | $-15.95 | $-12.82 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-17M | $-12M | · | $-8M | $-7M | $-15M | · | $-24M | $-18M | $-12M | · | $-5M | $-13M | $-13M | · | $-15M | |
| Market Cap | $32M | $27M | · | $12M | $361M | $259M | · | $400M | $436M | $516M | · | $83.47B | $189.12B | $203.67B | · | $309.05B | |
| P/E | -0.4 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | -1.4 | -17.4 | -25.8 | · | -114.7 | -282.1 | -402.5 | · | · | |
| P/S | 16.7 | 14.2 | · | 6.5 | 188.9 | 135.2 | · | 209.3 | 228.0 | 269.5 | · | 43631.5 | 98854.8 | 106456.6 | · | 161541.6 | |
| P/B | 2.0 | 1.3 | · | 0.9 | 68.5 | 29.8 | · | 23.9 | 4459.5 | 51.9 | · | 5385.1 | 17606.2 | 15554.0 | · | 16863.1 | |
| P / Tangible Book | 5.7 | · | · | 3.2 | · | · | · | 63.8 | · | · | · | 16687.4 | 777540.7 | 78468.0 | · | 39477.5 | |
| P / Cash Flow | · | -8.2 | · | · | · | -98.0 | · | · | · | -269.7 | · | · | · | -51279.9 | · | · | |
| Earnings Yield | -233.3% | -1722.0% | · | -24518.8% | -9127.2% | -3074.5% | · | -73.2% | -5.8% | -3.9% | · | -0.87% | -0.35% | -0.25% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-12M | $-23M | $-4M | $-15M | $-30M |
| Verwässerte EPS | $-8.66 | $-1080.87 | $-5.33 | $-11.74 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | · | 1.4 | 1.2 | 2.0 | 12.2 |
| Quick Ratio | · | 1.3 | 1.0 | 1.7 | 11.1 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 23 Einreicher · $2.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
23
Gehaltener Wert
$2.9M
Neue Positionen
6
Geschlossene Positionen
2
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (-1 vs. Vorquartal) | 2 (-5 vs. Vorquartal) | 5 (0 vs. Vorquartal) | 4 (+3 vs. Vorquartal) | +109K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Quinn Opportunity Partners LLC | $479.794 | 123.024 | 16,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $448.621 | 115.031 | 15,57% | Aktien |
| JANE STREET GROUP, LLC | $340.240 | 87.241 | 11,81% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $275.659 | 70.682 | 9,57% | Aktien |
| UBS Group AG | $229.686 | 58.894 | 7,97% | Aktien |
| Balyasny Asset Management L.P. | $224.999 | 57.692 | 7,81% | Aktien |
| VANGUARD GROUP INC | $211.733 | 53.066 | 7,35% | Aktien |
| ADAR1 Capital Management, LLC | $195.000 | 50.000 | 6,77% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $167.907 | 43.053 | 5,83% | Aktien |
| STATE STREET CORP | $98.690 | 25.305 | 3,43% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $74.326 | 19.058 | 2,58% | Aktien |
| NORTHERN TRUST CORP | $70.188 | 17.997 | 2,44% | Aktien |
| PEAK6 LLC | $49.834 | 12.778 | 1,73% | Aktien |
| Sunbelt Securities, Inc. | $6.038 | 1.750 | 0,21% | Aktien |
| Tower Research Capital LLC (TRC) | $4.068 | 1.043 | 0,14% | Aktien |
| BARCLAYS PLC | $3.705 | 950 | 0,13% | Aktien |
| SBI Securities Co., Ltd. | $390 | 100 | 0,01% | Aktien |
| HRT FINANCIAL LP | $196 | 50.373 | 0,01% | Aktien |
| BlackRock, Inc. | $74 | 19 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $35 | 9 | 0,00% | Aktien |
| PIN OAK INVESTMENT ADVISORS INC | $14 | 3.500 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $7 | 2 | 0,00% | Aktien |
| Wilmington Savings Fund Society, FSB | $4 | 1 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Samuel Duffey, Individually | 8. September 2022 | · | Erste Einreichung | · | SEC |
| Caroline Williams, Individually and as Trustee of the Starwood Trust, The Starwood Trust | 27. April 2021 | · | Erste Einreichung | · | SEC |
| Thomas J. Knox | 18. Februar 2014 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 24 Insider · 9 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Howard Yeaton | CEO, CFO | 2. Oktober 2019 A | 45.000 | 0 | 0 | $0 |
| John J Gormally | Chief Executive Officer | 17. Oktober 2017 A | 180.000 | 0 | 0 | $0 |
| Ian Rhodes | Interim CFO | 17. April 2025 A | · | 0 | 0 | $0 |
| Christopher C Chapman JR | President, Chief Med. Officer | 7. Juni 2023 A | 96.475 | 0 | 0 | $0 |
| Mitchell Glass | Chief Medical Officer | 13. April 2026 A | 12.500 | 0 | 0 | $0 |
| Joshua Silverman | Executive Chairman | 13. April 2026 A | 116.835 | 0 | 0 | $0 |
| Paul Rivard | Chief Legal Officer | 24. August 2023 P | 400.000 | 0 | 0 | $0 |
| Adam Kaplin | Chief Scientific Officer | 7. Juni 2023 A | · | 0 | 0 | $0 |
| Raymond Francis Akers JR | Executive Chairman, Secretary | 5. Januar 2016 P | 72.100 | 0 | 0 | $0 |
| Stephen Friscia | Direktor | 13. April 2026 A | 25.000 | 0 | 0 | $0 |
| Bruce Bernstein | Direktor | 13. April 2026 A | 25.000 | 0 | 0 | $0 |
| Billy Joe White | Direktor | 13. April 2026 A | 25.024 | 0 | 0 | $0 |
| Chelsea Sierra Voss | Direktor | 30. März 2026 P | 61.555 | 1 | 0 | $5.522 |
| Jude Uzonwanne | Direktor | 7. Juni 2023 A | · | 0 | 0 | $0 |
| Christopher C Schreiber | Direktor | 7. Juni 2023 A | 88.238 | 0 | 0 | $0 |
| Craig Eagle | Direktor | 7. Juni 2023 A | · | 0 | 0 | $0 |
| Robert C Schroeder | Direktor | 16. April 2021 M | 29.236 | 0 | 0 | $0 |
| Raza Bokhari | Direktor | 30. Dezember 2015 A | 32.083 | 0 | 0 | $0 |
| Robert E Andrews | Direktor | 30. Dezember 2015 A | 48.125 | 0 | 0 | $0 |
| Brandon Thomas Knox | Direktor | 30. Dezember 2015 A | 138.076 | 0 | 0 | $0 |
| Gavin Moran | Direktor | 9. Januar 2015 A | 35.000 | 0 | 0 | $0 |
| Thomas J Knox | Direktor | 9. Januar 2015 A | 408.150 | 0 | 0 | $0 |
| PharmaCyte Biotech, Inc. | 10%-Eigentümer | 14. November 2025 P | · | 0 | 0 | $0 |
| Gary M Rauch | · | 14. November 2025 A | 12.500 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| QCLS | · | -0.5 | · | · | · | · |
| JAGX | · | -0.0 | -1.5% | -465.4% | 907.4% | · |
| ENVB | $4M | -0.1 | -94.1% | 8275459.4% | -275.8% | · |
| RVPH | $2M | · | · | · | -485.2% | · |
| SNOA | $4M | -1.1 | 36.7% | -16.3% | -92.3% | 38.0% |
| PULM | $8M | -1.6 | 7.0% | · | -109.7% | · |
| SXTP | · | · | · | · | · | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026